P/E ratio for Haemonetics (HAE)

P/E ratio history for Haemonetics from 2001 to 2023

PE ratio at the end of each year

P/E ratio for similar companies or competitors

Company	P/E ratio	P/E ratio differencediff.	Country
Thermo Fisher Scientific TMO	33.8	11.87%	🇺🇸 USA
Stryker Corporation SYK	53.2	75.94%	🇺🇸 USA
Becton Dickinson BDX	40.8	34.98%	🇺🇸 USA
Cerus CERS	-5.34	-117.68%	🇺🇸 USA
Baxter BAX	5.59	-81.51%	🇺🇸 USA
PerkinElmer PKI	15.0	-50.50%	🇺🇸 USA
Johnson & Johnson JNJ	10.2	-66.34%	🇺🇸 USA
Medtronic MDT	29.3	-3.20%	🇮🇪 Ireland

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.